Ashland Inc. (ASH)
Company Description
Ashland Inc. provides additives and specialty ingredients worldwide.
It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments.
The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions.
The Personal Care & Household segment provides a range of nature-based, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers.
The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding.
The Intermediates and Solvents segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone.
It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical.
The company was formerly known as Ashland Global Holdings Inc.
Ashland Inc. was founded in 1924 and is based in Wilmington, Delaware.

Country | United States |
IPO Date | Mar 17, 1980 |
Industry | Chemicals - Specialty |
Sector | Basic Materials |
Employees | 3,200 |
CEO | Guillermo Novo |
Contact Details
Address: 8145 Blazer Drive Wilmington, Delaware United States | |
Website | https://www.ashland.com |
Stock Details
Ticker Symbol | ASH |
Exchange | NYSE |
Fiscal Year | October - September |
Reporting Currency | USD |
CIK Code | 0001674862 |
CUSIP Number | 044186104 |
ISIN Number | US0441861046 |
Employer ID | 81-2587835 |
SIC Code | 5160 |
Key Executives
Name | Position |
---|---|
Guillermo Novo | Chairman & Chief Executive Officer |
Dr. Osama M. Musa Ph.D. | Senior Vice President & Chief Technology Officer |
William C. Whitaker C.F.A. | Interim Chief Financial Officer, Vice President of Finance & Director of Investor Relations |
Alessandra Faccin Assis | Senior Vice President and GM of Life Sciences & Intermediates |
Karl R. Bostaph | Senior Vice President of Operations |
Michael Coppola | Treasurer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 20, 2025 | 4 | Filing |
May 20, 2025 | 3 | Filing |
May 19, 2025 | 4 | Filing |
May 19, 2025 | 3 | Filing |
May 12, 2025 | 4 | Filing |
May 08, 2025 | 4 | Filing |
May 05, 2025 | 8-K | Current Report |
May 01, 2025 | 10-Q | Quarterly Report |
Apr 30, 2025 | 8-K | Current Report |
Apr 17, 2025 | SCHEDULE 13G/A | [Amend] Filing |